Draft notice: the cited evidence library for this article is in preparation. The Muscle Guard research team is finishing the source review. The full question-shaped answer, primary sources, and Muscle Guard tracking integration will publish here. Subscribe at research@muscleguardglp.com to be told when it ships.
What this article will cover
This guide is part of the Muscle Guard Research Hub. When complete it will include:
- A direct, citation-anchored answer to "Rybelsus and oral semaglutide: how it compares to weekly shots"
- The published evidence base for the underlying claims
- Practical, named guidance for users on a GLP-1
- What Muscle Guard tracks for you, mapped to the evidence
Read in the meantime
While this article is being written, the cornerstone — Do you lose muscle on a GLP-1? — covers the foundation of every other piece in the library.
Related articles
Mounjaro vs Ozempic vs Wegovy — the comparison
How tirzepatide (Mounjaro / Zepbound) compares to semaglutide (Wegovy / Ozempic) on efficacy, side effects, cost, and muscle preservation. Drug-by-drug, evidence-based.
GLP-1 side effects, week by week
What to expect from Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, and Saxenda — week by week, dose by dose. Nausea, fatigue, GI symptoms, and when to call your doctor.
GLP-1s in South Africa 2026: access, pricing, and the compounded landscape
What South Africans actually pay for Ozempic, Mounjaro, and compounded semaglutide in 2026. Medical aid coverage, pharmacy options, and tracking with ZAR pricing.
Track this with Muscle Guard
The free app that puts muscle preservation in the headline. 7-day Pro trial, no card needed.
Get the app →Muscle Guard is a self-tracking companion and coach. Not a medical device. Not medical advice. Always consult your healthcare provider for personal decisions.